Trials / Completed
CompletedNCT00153140
Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 239 (planned)
- Sponsor
- Braintree Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to compare the safety and efficacy of extended polyethyleneglycol3350 use to tegaserod in patients with chronic constipation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | polyethyleneglycol3350 |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2004-10-01
- First posted
- 2005-09-12
- Last updated
- 2013-02-07
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00153140. Inclusion in this directory is not an endorsement.